article thumbnail

How Will Ultima Genomics and Genome Insight Make WGS Affordable?

XTalks

The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of cancer researchers even before the first human genome was decoded in 2003. Ultima Genomics has already partnered with other leading biotech startups.

Genome 97
article thumbnail

Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients

STAT News

Stanford cardiologist Euan Ashley and his research team received a Guinness World Record last year for sequencing a full human genome in just over five hours. He says that’s just the beginning. Ashley is at the forefront of a push by researchers to make more genetic information available to patients facing major health care decisions.

Genome 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The use of genomic profiling testing to improve oncology care

pharmaphorum

Across LabCorp , we innovate through science and technology, with access to approximately 2,500 [doctors] and PhDs and over 700 patients. The test informs HCPs through a comprehensive genomic and immune profiling test clinically and analytically validated for all solid tumours. Tailored oncology.

Genome 101
article thumbnail

Personalising whole genome sequencing doubles diagnosis of rare diseases 

Drug Discovery World

A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases. . Consequently, the UK has established itself at the forefront of diagnostic whole genome sequencing. Context .

Genome 52
article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Yellow Card biobank will launch as a joint venture with the UK-government funded entity Genomics England on June 1. This would ideally allow doctors to use rapid genomic screening tests that can help them to select the safest potential treatment for a patient.

article thumbnail

ReceptorNet Helps Doctors Make Clinical Decisions for Breast Cancer Treatment

BioSpace

Part of the difficulty of treating breast cancer is the genomic variability of the patient population, as well as the different forms the cancer can take.

Doctors 102
article thumbnail

UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first

pharmaphorum

Genomics England, the Department of Health and Social Care’s genome-sequencing hub, has this year announced that support for whole genome sequencing (WGS) has reached a level at which its national rollout on the NHS may someday become a reality. Only when genomic databases are diverse can we ensure that we all benefit equally.

Genome 110